At the interface between the innate and adaptive immune system, dendritic cells (DCs) play
key roles in tumour immunity and hold a hitherto unrealized potential for cancer …

Chronic inflammation increases the risk of several cancers, including gastric, colon, and
hepatic cancers. Conversely, tumors, similar to tissue injury, trigger an inflammatory …

Dendritic cells (DCs) represent a small and heterogeneous fraction of the hematopoietic
system, specialized in antigen capture, processing, and presentation. The different DC …

Despite a decrease in gastric cancer incidence, the development of novel biologic agents
and combined therapeutic strategies, the prognosis of gastric cancer remains poor …

Dendritic cells (DCs) are potent inducers of T cell immunity, and autologous DC vaccination
holds promise for the treatment of cancers and chronic infectious diseases. In practice …

Cancer progression involves multiple genetic and epigenetic events, which involve gain-of-
functions of oncogenes and loss-of-functions of tumor suppressor genes. Classical tumor …

The incidence of gastric cancer (GC) fell dramatically over the last 50 years, but according to
IARC-Globocan 2008, it is the third most frequent cause of cancer-related deaths with a case …

Better prognoses associated with increased T cell infiltration of tumors, as seen with
chimeric antigen receptor (CAR) T cell therapies and immune checkpoint inhibitors, portray …

Mounting preclinical and clinical evidence indicates that rewiring the host immune system in
favor of an antitumor microenvironment achieves remarkable clinical efficacy in the …

Selenium levels can regulate the function of T cells, macrophages, B cells, natural killer cells
and other immune cells. However, the effect of selenium on the immune function of dendritic …